New shot aims to stop agony after shoulder surgery
NCT ID NCT07196631
Summary
This study is testing two different numbing medicines given as a nerve block to control pain after shoulder surgery. It aims to see if a newer, longer-lasting medicine (liposomal bupivacaine) is better than a standard one (ropivacaine) at preventing severe 'rebound pain' that often hits patients when the initial block wears off. The trial involves 100 adults having arthroscopic shoulder surgery and will measure pain levels and medication use for 72 hours.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REBOUND PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430030, China
Conditions
Explore the condition pages connected to this study.